Intelligence Feed event · Equity · 2026-10-13

    Abbott Rises 2.23% to $101.82 Ahead of October 21 Q3 Earnings Release

    Question

    Abbott Rises 2.23% to $101.82 Ahead of October 21 Q3 Earnings Release

    Direct answer

    Abbott Laboratories gained 2.23% to settle at $101.82 on October 12, 2026, exhibiting relative strength as broader market benchmarks moved lower. The advance comes ahead of the company's scheduled third-quarter earnings release on October 21, 2026. Consensus projections anticipate 9.23% year-over-year EPS growth to $1.42 alongside a 13.52% revenue expansion to $12.91 billion, supported by consistent medical device segment volumes.

    Original publisher
    Market Ontology
    Evidence through
    2026-10-13
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Abbott Rises 2.23% to $101.82 Ahead of October 21 Q3 Earnings Release”, revision 1, evidence through 2026-10-13. https://marketontology.com/market-events/2026-10-13/abbott-rises-2-23-to-101-82-ahead-of-october-21-q3-earnings-release-8d80e9

    EQUITY
    Abbott Rises 2.23% to $101.82 Ahead of October 21 Q3 Earnings Release
    Abbott Laboratories gained 2.23% to settle at $101.82 on October 12, 2026, exhibiting relative strength as broader market benchmarks moved lower. The advance comes ahead of the company's scheduled third-quarter earnings release on October 21, 2026. Consensus projections anticipate 9.23% year-over-year EPS growth to $1.42 alongside a 13.52% revenue expansion to $12.91 billion, supported by consistent medical device segment volumes.
    ABT
    Impact
    68
    OCT 13
    SIG
    88%
    ABT
    Abbott Rises 2.23% to $101.82 Ahead of October 21 Q3 Earnings Release
    Abbott Laboratories gained 2.23% to settle at $101.82 on October 12, 2026, exhibiting relative strength as broader market benchmarks moved lower. The advance comes ahead of the company's scheduled third-quarter earnings release on October 21, 2026. Consensus projections anticipate 9.23% year-over-year EPS growth to $1.42 alongside a 13.52% revenue expansion to $12.91 billion, supported by consistent medical device segment volumes.
    → Expanding medical device and diagnostic revenue streams support ABT defensive earnings quality, attracting pre-earnings rotation into healthcare.
    Impact
    Abbott Laboratories gained 2.23% to settle at $101.82 on October 12, 2026, exhibiting relative strength as broader market benchmarks moved lower. The advance comes ahead of the company's scheduled third-quarter earnings release on October 21, 2026. Consensus projections anticipate 9.23% year-over-year EPS growth to $1.42 alongside a 13.52% revenue expansion to $12.91 billion, supported by consistent medical device segment volumes.
    Affected
    ABT
    Transmission
    Expanding medical device and diagnostic revenue streams support ABT defensive earnings quality, attracting pre-earnings rotation into healthcare.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    ABTdefensive healthcare inflows and projected double-digit top-line expansionUp1-4wSource reported ABT rose 2.23% to $101.82 with Q3 revenue projected up 13.52% YoY to $12.91B and Zacks Rank #2.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    Price follow-up pending — no stored daily closes for these assets yet.

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month